Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction.

Cholinergic lesion paradigms have been used to study the role of the cholinergic system in cortical arousal and cognitive function, and its implication in cognitive deficits that occur in Alzheimer's disease. In the last few years an increasing number of studies have applied neurotoxins including excitotoxins or cholinotoxins (e.g. AF64A) by stereotaxic injection into the Nbm to produce reductions in cortical cholinergic activity. One of the most serious limitations of these lesion paradigms is the fact that basal forebrain cholinergic neurons are always intermingled with populations of noncholinergic cells and that the cytotoxins used are far from being selective to cholinergic cells. Excitoxins when infused directly into the Nbm destroy non-specifically cell bodies but spare axons passing the injection site, whereas the specificity of AF64A to destroy cholinergic neurons depends on both the dosage applied and the site of injection. Recently, a monoclonal antibody to the low-affinity nerve growth factor (NGF) receptor, 192IgG, coupled to a cytotoxin, saporin, has been described as an efficient and selective immunotoxin for the NGF-receptor bearing cholinergic neurons in rat basal forebrain. Intraventricular administration of the 192IgG-saporin conjugate appears to induce a nearly complete and specific lesion of neocortical and hippocampal cholinergic afferents. Other neuronal systems in the basal forebrain are spared by the immunotoxin. Electrolytic, ibotenic acid, and cholinergic immunotoxic lesions of cholinergic basal forebrain nuclei resulted in slightly different effects on cortical cholinergic markers: Electrolytic lesion of the Nbm did not change M1-mAChR but resulted in reduced M2-mAChR in frontal and parietal cortices 1 week after lesion. Ibotenic acid lesion of the nucleus basalis did not alter M1-mAChR in any cortical region but led to enhanced M2-mAChR binding in the parietal cortex only. When applying the cholinergic immunotoxin 192IgG-saporin, both M1- and M2-mAChR binding sites were increased in a number of cortical areas 1 week after lesion. This comparison suggests that possibly the destruction of non-cholinergic basal forebrain cells by ibotenic acid and electrolytic lesion, might partly contribute to these different cortical effects. NMDA receptor binding was markedly reduced and AMPA, kainate, and GABAA receptor binding has been significantly increased in cortical regions displaying a reduced activity of AChE and decreased levels of high-affinity choline uptake sites due to immunolesion of the basal forebrain cholinergic system. Equivalent changes in cortical glutamate and GABA receptor subtype levels have been observed 7 days after electrolytic or ibotenic acid lesion of the Nbm. The data suggest that cholinergic immunolesion by 192IgG-saporin exhibits a valuable tool to produce specific cholinergic deficits in rats, which can be used as a model to study the effect of treatment with various drugs for compensating the impaired cortical cholinergic input.

[1]  J. Penney,et al.  NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex , 1993, Neurobiology of Aging.

[2]  V. Bigl,et al.  192IgG‐saporin immunotoxin‐induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei , 1995, Journal of neuroscience research.

[3]  A. Björklund,et al.  Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. , 1992, Neuroreport.

[4]  B. Kolb,et al.  The Cerebral cortex of the rat , 1990 .

[5]  H. Hydén,et al.  Localization and response of the 14‐3‐2 brain protein , 1975, Journal of neuroscience research.

[6]  V. Bigl,et al.  1921gG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus , 1995, Brain Research Bulletin.

[7]  Karl J. Zilles,et al.  The Cortex of the Rat: A Stereotaxic Atlas , 1985 .

[8]  P. Potter,et al.  Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A) , 1989, Brain Research.

[9]  V. Bigl,et al.  Differential expression of immediate early genes in distinct layers of rat cerebral cortex after selective immunolesion of the forebrain cholinergic system , 1994, Journal of neuroscience research.

[10]  U. Meyer,et al.  Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats , 1980, Brain Research Reviews.

[11]  V. Bigl,et al.  Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions , 1994, Brain Research.

[12]  L. Butcher,et al.  Is ethylcholine mustard aziridinium ion a specific cholinergic neurotoxin? , 1987, Neuroscience.

[13]  J. Penney,et al.  A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions , 1991, Brain Research.

[14]  L. Thal,et al.  192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells , 1995, Neuroscience.

[15]  S. Heckers,et al.  Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  L. Butcher,et al.  Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon , 1989, Neuroscience.

[17]  Prof. Dr. Karl Zilles The Cortex of the Rat , 1985, Springer Berlin Heidelberg.

[18]  R. Olsen,et al.  GABAA Receptor Subtypes: Ligand Binding Heterogeneity Demonstrated by Photoaffinity Labeling and Autoradiography , 1993, Journal of neurochemistry.

[19]  V. Bigl,et al.  Receptor function in cortical rat brain regions after lesion of nucleus basalis. , 1994, Journal of neural transmission. Supplementum.

[20]  A. Nordberg,et al.  Neuroreceptor changes in Alzheimer disease. , 1992, Cerebrovascular and brain metabolism reviews.

[21]  R. Beninger,et al.  Excitotoxic lesions of rat basal forebrain: Differential effects on choline acetyltransferase in the cortex and amygdala , 1992, Neuroscience.

[22]  R. Wiley Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning , 1992, Trends in Neurosciences.

[23]  C. Advokat,et al.  Excitatory amino acids and memory: Evidence from research on Alzheimer's disease and behavioral pharmacology , 1992, Neuroscience & Biobehavioral Reviews.

[24]  R. Wiley,et al.  Specificity of 192 IgG-saporin for NGF receptor-positive cholinergic basal forebrain neurons in the rat , 1992, Brain Research.

[25]  F. Gage,et al.  NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum , 1989, Neuron.

[26]  P S Goldman-Rakic,et al.  Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  V. Bigl,et al.  Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system , 1995, Journal of neuroscience research.

[28]  B. Anand,et al.  Single neurone activity of hypothalamic feeding centres: effect of local heating. , 1966, Brain research.

[29]  F. Eckenstein,et al.  An anatomical study of cholinergic innervation in rat cerebral cortex , 1988, Neuroscience.

[30]  G. Sperk,et al.  Cholinergic Deficit Induced by Ethylcholine Aziridinium (AF64A) Transiently Affects Somatostatin and Neuropeptide Y Levels in Rat Brain , 1990, Journal of neurochemistry.

[31]  T. Stone CNS Neurotransmitters and Neuromodulators: Acetylcholine , 1994 .

[32]  John M. Lee,et al.  Septal choline acetyltransferase immunoreactive neurons: Dose-dependent effects of AF64A , 1991, Brain Research Bulletin.

[33]  A. Björklund,et al.  Selective Lesioning of the Basal Forebrain Cholinergic System by Intraventricular 192 IgG–saporin: Behavioural, Biochemical and Stereological Studies in the Rat , 1995, The European journal of neuroscience.

[34]  J. Gobert,et al.  Behavioural and histological effects of low concentrations of intraventricular AF64A. , 1989, European journal of pharmacology.

[35]  L. Wilkinson,et al.  Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system , 1994, Neuroscience.

[36]  G. Wenk,et al.  Basal forebrain neurons and memory: a biochemical, histological, and behavioral study of differential vulnerability to ibotenate and quisqualate. , 1992, Behavioral neuroscience.

[37]  G. Buzsáki,et al.  Hippocampal theta activity following selective lesion of the septal cholinergic systeM , 1994, Neuroscience.

[38]  T. Stone,et al.  CNS Neurotransmitters and Neuromodulators: Dopamine , 1996 .

[39]  A. Fisher,et al.  Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity. , 1986, Annual review of pharmacology and toxicology.

[40]  T. J. Walsh,et al.  AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates , 1988, Brain Research.

[41]  D. Sengelaub,et al.  Alterations in dendritic morphology of frontal cortical neurons after basal forebrain lesions in adult and aged rats , 1995, Brain Research.

[42]  J. Schweitzer,et al.  Immunohistochemical detection of a monoclonal antibody directed against the NGF receptor in basal forebrain neurons following intraventricular injection , 1991, Journal of Neuroscience Methods.

[43]  R. McBurney Therapeutic potential of NMDA antagonists in neurodegenerative diseases , 1994, Neurobiology of Aging.

[44]  S. L. Mobley,et al.  Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  K. Dziegielewska,et al.  Acute-phase α2-macroglobulin in csf during development of the fetal rat , 1983, International Journal of Developmental Neuroscience.

[46]  Q. Yan,et al.  Immunohistochemical localization and biochemical characterization of nerve growth factor receptor in adult rat brain , 1989, The Journal of comparative neurology.

[47]  V. Bigl,et al.  Postnatal development of NMDA, AMPA and kainate receptors in individual layers of rat visual cortex and the effect of monocular deprivation , 1994, International Journal of Developmental Neuroscience.

[48]  V. Bigl,et al.  192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions , 1995, Brain Research.

[49]  Larry L. Butcher,et al.  Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis , 1982, Brain Research Bulletin.

[50]  R. Wiley,et al.  Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor , 1991, Brain Research.

[51]  Stephen B. Dunnett,et al.  The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions , 1991, Trends in Neurosciences.

[52]  P. Seeburg The TiPS/TINS lecture: the molecular biology of mammalian glutamate receptor channels. , 1993, Trends in pharmacological sciences.

[53]  T. J. Walsh,et al.  Hemicholinium-3 prevents the working memory impairments and the cholinergic hypofunction induced by ethylcholine aziridinium ion (AF64A) , 1989, Brain Research.

[54]  R. Wiley,et al.  192 IgG-saporin : I. Specific Lethality for Cholinergic Neurons in the Basal Forebrain of the Rat , 1994, Journal of neuropathology and experimental neurology.